Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine
Could a corporate, direct-to-consumer cell-based testing service be the next 23andme? And what would that mean for patients?

Within South Africa’s science policy landscape, two recent proposals highlight an ideological struggle between individual freedom and central control.

What does it mean when our devices recognize us more accurately when we utter the dialect of consumerism?

Equipping cancer survivors with an effective right to be forgotten is essential in picking up life after recovery.

Petrie-Flom Center intern James René Jolin and Executive Director Susannah Baruch discuss the FDA’s approval of over-the-counter birth control.

An overview of the normative landscape of medical AI in Europe, beyond the borders of the EU and its 27 Member States.
